Clinical Trial Update: Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether melatonin can prevent brain injury in unborn babies with fetal growth restriction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Monash University | Conditions: Fetal Growth Retardation | Phase 4 | Status: COMPLETED